Roberto D. Polakiewicz, PhD profile page

Roby leads research, product, and technology innovation at CST®, driving the development of the company’s most valuable products, technologies, and intellectual property. He has spearheaded the creation and implementation of novel antibody technology platforms that have been instrumental to CST’s success. Previously, he served as Director of Research and Vice President of Research at CST, and before joining the company in 1999, he was a staff scientist at the biotechnology firm New England Biolabs. He earned a BS in Chemistry and a PhD in Molecular Biology from the Hebrew University of Jerusalem, Israel, and completed postdoctoral studies at the Whitehead Institute for Biomedical Research at the Massachusetts Institute of Technology (MIT), USA. Roby has published approximately 65 peer-reviewed scientific articles and is a named inventor on numerous patents and patent applications.